RESEARCH, TECHNOLOGY TRANSFER and REGIONAL DEVELOPMENT seeking cancer triggers A major grant under the Sir Henry Wellcome Commemorative Award scheme funded important cancer research. This is only the second time such a grant has been awarded to scientists in Northern Ireland. The Cancer and Ageing Research Group has been investigating how
signalling systems within individual cells works. Professor Stephen Downes,
Head of the group says: “This grant has enabled us to search for a new mechanism which controls cell growth. If we can discover such a mechanism, we will be able to find out if it goes wrong in the case of cancer. If we can find out what goes wrong, then we can hope to find out how to put it right”.
clinical
trials
for
cancer
drug The revolutionary tumour-busting drug cancer drug AQ4N is the result of ten years of work by Professor Stephanie McKeown of the University Radiation Science Research team. It went into clinical trials in England this year. Speaking of the drug’s properties, Professor McKeown said: “We are confident that AQ4N will enhance the effectiveness of contemporary anti-cancer treatments, as it can reach and destroy hypoxic tumour cells that are resistant to radiation and existing chemotherapy techniques.” If you
have any comments on these webpages, please send them to: |